Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review

Targeting Metabolic Consequences of Insulin Resistance in Polycystic Ovary Syndrome by D-chiro-inositol and Emerging Nutraceuticals: A Focused Review

Polycystic ovary syndrome (PCOS) is a complex disorder associated with ovarian dysfunction, infertility, menstrual irregularity, and hormonal impairments. Over the last decade, several studies have shown that some PCOS women have insulin resistance (InsR) and hyperinsulinemia, apart from being overw...

Full description

Bibliographic Details
Main Authors: Sergio Davinelli, Daria Nicolosi, Cinzia Di Cesare, Giovanni Scapagnini, Roberto Di Marco
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Journal of Clinical Medicine
Subjects:
polycystic ovary syndrome
d-chiro-inositol
nutraceuticals
insulin resistance
diabetes
Online Access:https://www.mdpi.com/2077-0383/9/4/987

Internet

https://www.mdpi.com/2077-0383/9/4/987

Similar Items